Given the critical role of REV-ERBα/BMAl1 in the development of HFD-induced obesity, it is of interest to test whether REV-ERBα/BMAL1 can be targeted to prevent this metabolic disorder. Here, BMAL1 is linked to obesity due to melanocortin 4 receptor deficiency.